Co-Director, Better Treatments Program

Hiddo J. Lambers Heerspink is a Professor of Clinical Trials and Personalized Medicine and a clinical pharmacologist/trialist at the Department of Clinical Pharmacy and Pharmacology at the University Medical Center Groningen. Professor Lambers Heerspink’s research interests focus on optimizing current treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular diseases in patients with diabetes. He is active in clinical trials focused on renal and cardiovascular complications of type 2 diabetes. He served as a member of the Work Group that developed the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Diseases. He is an editorial board member of the Clinical Journal of the American Society of Nephrology.


Leave a Reply

Your email address will not be published.

8 + fifteen =